63 / 84
303
Ces Urol 2015; 19(4): 296–303
ORIGINÁLNÍ PRÁCE
3. Van de Water L.
Mechanisms by which fibrin and fibronectin appear in healing wounds: implications
for Peyronie´s disease. J Urol 1997; 157: 306–310.
4. Devine CJ.
Introduction to Peyronie´s Disease. J Urol 1997; 157: 272–275.
5. Williams G, Green NA.
The non-surgical treatment of Peyronie´s disease. Br J Urol 1980, 52: 392–395.
6. Yaschia D.
Corporal plication for surgical of Peyronie´s disease. J Urol 1993; 149: 869.
7. Levine LA.
Review of current nonsurgical management of Peyronie´s disease. Int J Import Res 2003; 15:
113–120.
8. Hauck EW, Altinkilic BM, Ludwig M, et al.
Extracorporeal shock wave therapy in the treatment of Pey‑
ronie´s disease. First results of a case-controlled approach. Eur Urol 2000; 38: 663–669.
9. Hatzichristodoulou G, Meisner C, et al.
Efficasy of extracorporeal shock wave therapy on plaque size
and sexual function in patiens with Peyronie´s disease – results of a prospective, randomized, placebo‑
-controlled study. Annual meeting of the Američan urological Association, 2007.
10. Abdel-Salam Y, Budair Z, Renner C, et al.
Treatment of Peyronie´disease by extracorporeal shockwave
therapy: evaluation of our preliminary results. J Endourol 1999; 13: 549–552.
11. Srirangam SJ, Manikandan R, Hussain J, et al.
Long-term results of extracorporeal shockwave therapy.
J Endourol 2006; 20: 880–884.
12. Skolarikos A, Alargof E, et al.
Shockwave therapy as first-line treatment for Peyronie´s disease: a pro‑
spective study. J Endourol 2005; 19: 11–14.
13. Lebret T, Loison G, Hervé JM, et al.
Extracorporeal shock wave therapy in the fragment of Peyronie´s di‑
sease: experience with standart lithotriptor (siemens-multiline). Urology 2000; 59: 657–61.
14. Poulakis V, Skriapas K, de Vries R, et al.
Extracorporeal shockwave therapy for Peyronie´s disease: an
alternative treatment? Asian J Androl 2006; 8: 361–366.
15. Palmieri A, Imbimbo C, Longo N, et al.
A first prospective, randomized, double-blind, placebo-con‑
trolled clinical trial evaluating extracorporeal shock wave therapy for treatment of Peyronie´s disease. Eur
urol 2009; 56: 363–369.
16. Drlík P, Kohler O.
Naše zkušenosti s aplikací rázové vlny u pacientů s induratio penis plastica (průměrná
doba sledování 13 měsíců). Ces Urol 2010; 14(3): 1–3.
17. Drlík P, Loško J, Křístek V, Kohler O.
Matematické modelování deformace penisu při induratio penis
plastica po terapii rázovými vlnami (SWT). Ces urol 2012; 16(1): 37–42.
18.
Hatzichristodoulou G, Meisner C, Gschwend JE, et al.
Extracorporeal shock wave therapy in Peyro‑
nie’s disease: results of a placebo-controlled, prospective, randomized single-blind study. J Sex Med. 2013;
10: 2815–2821.